• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYHB2300291 甲磺酸达拉非尼胶囊 dabrafenib mesylate Capsule Chemical Drugs Supplementary Application 2023-05-17 Siegfried Barbera SL;Lek Pharmaceuticals DD;Novartis Europharm Ltd view
JXHB2400175 甲磺酸达拉非尼胶囊 dabrafenib mesylate Capsule Chemical Drugs(2.4) Supplementary Application 2024-11-09 Novartis Europharm Ltd view
JYHB2002354 甲磺酸达拉非尼胶囊 dabrafenib mesylate Capsule Chemical Drugs Supplementary Application 2020-11-20 北京诺华制药有限公司 Beijing Novartis Pharma Co Ltd;Glaxo Operations UK Ltd;Novartis Europharm Ltd Certificate Issued 2021-02-03 view
JXHS2101046 甲磺酸达拉非尼胶囊 dabrafenib mesylate Capsule Chemical Drugs(5.1) Import Drug Application 2021-09-06 Beijing Novartis Pharma Co Ltd;Novartis Farmaceutica SA;Novartis Europharm Ltd view
JYHZ2400112 甲磺酸达拉非尼胶囊 dabrafenib mesylate Capsule Chemical Drugs License Renew 2024-05-11 Siegfried Barbera SL;Beijing Novartis Pharma Co Ltd;Novartis Europharm Ltd view
JYHB2000620 甲磺酸达拉非尼胶囊 dabrafenib mesylate Capsule Chemical Drugs Supplementary Application 2020-06-03 北京诺华制药有限公司 Beijing Novartis Pharma Co Ltd;Novartis Farmaceutica SA;Novartis Europharm Ltd Certificate Issued 2021-10-15 view
JXHL2101129 甲磺酸达拉非尼胶囊 dabrafenib mesylate Capsule Chemical Drugs(2.4) Import Drug Application 2021-07-09 Novartis Europharm Ltd view
JYHB2400252 甲磺酸达拉非尼胶囊 dabrafenib mesylate Capsule Chemical Drugs Supplementary Application 2024-05-30 Siegfried Barbera SL;Novartis Europharm Ltd view
JYHB2000746 甲磺酸达拉非尼胶囊 dabrafenib mesylate Capsule Chemical Drugs Supplementary Application 2020-06-10 北京诺华制药有限公司 Beijing Novartis Pharma Co Ltd;Glaxo Operations UK Ltd;Novartis Europharm Ltd Filed 2020-06-19 view
JYHB2101509 甲磺酸达拉非尼胶囊 dabrafenib mesylate Capsule Chemical Drugs Supplementary Application 2021-11-08 Novartis Farmaceutica SA;Novartis Europharm Ltd view
JYHB2300552 甲磺酸达拉非尼胶囊 dabrafenib mesylate Capsule Chemical Drugs Supplementary Application 2023-09-21 Siegfried Barbera SL;Novartis Europharm Ltd view
JYHB2400659 甲磺酸达拉非尼胶囊 dabrafenib mesylate Capsule Chemical Drugs Supplementary Application 2024-12-17 Novartis Europharm Ltd view
JXHL2101128 甲磺酸达拉非尼胶囊 dabrafenib mesylate Capsule Chemical Drugs(2.4) Import Drug Application 2021-07-09 Novartis Europharm Ltd view
JYHB2300194 甲磺酸达拉非尼胶囊 dabrafenib mesylate Capsule Chemical Drugs Supplementary Application 2023-03-25 Siegfried Barbera SL;Novartis Europharm Ltd view
JYHB2000747 甲磺酸达拉非尼胶囊 dabrafenib mesylate Capsule Chemical Drugs Supplementary Application 2020-06-10 北京诺华制药有限公司 Beijing Novartis Pharma Co Ltd;Glaxo Operations UK Ltd;Novartis Europharm Ltd Filed 2020-06-19 view
JYHB2101508 甲磺酸达拉非尼胶囊 dabrafenib mesylate Capsule Chemical Drugs Supplementary Application 2021-11-08 Novartis Farmaceutica SA;Novartis Europharm Ltd view
JYHB2300550 甲磺酸达拉非尼胶囊 dabrafenib mesylate Capsule Chemical Drugs Supplementary Application 2023-09-21 Siegfried Barbera SL;Novartis Europharm Ltd view
JYHB2400658 甲磺酸达拉非尼胶囊 dabrafenib mesylate Capsule Chemical Drugs Supplementary Application 2024-12-17 Novartis Europharm Ltd view
JXHL2200182 甲磺酸达拉非尼胶囊 dabrafenib mesylate Capsule Chemical Drugs(2.4) Import Drug Application 2022-07-14 China Novartis Institutes For Biomedical Research Co Ltd;Novartis Europharm Ltd view
JYHB2300193 甲磺酸达拉非尼胶囊 dabrafenib mesylate Capsule Chemical Drugs Supplementary Application 2023-03-25 Siegfried Barbera SL;Novartis Europharm Ltd view